Infectious Disease Diagnostics Market Comprehensive Industry Report Offers Forecast and Analysis on 2021-2028

Infectious Disease Diagnostics Market report is an in-depth analysis study offered which explains necessary aspects like competition, segmentation, and regional growth in excessive detail. As a part of competitive analysis, the analysis study includes thorough company identification of leading players of the Infectious Disease Diagnostics Industry.

Infectious Disease Diagnostics Market report provides emerging opportunities in the market and the future impact of major drivers and challenges and, support decision makers in making cost-effective business decisions. One of the objectives of this report is to identify the latest developments, market shares, and strategies employed by the major market players. Besides, the least competitive market niches with significant growth potential are also identified. For research methodology, secondary research, primary research, subject matter expert advice, quality check, and final review was utilized.

Request Here PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/1971

Various laboratory techniques are utilized for disease diagnostics for identification of test samples such as blood and urine for identification and quantification of infective agents. Moreover, providing diagnosis based only on symptoms is challenging, as two or more diseases can exhibit similar symptoms, therefore diagnostic tests are utilized for confirmation of the disease. Diagnostic tests offers rapid and precise results, thereby saving time and provides physicians’ ample time for treatment.

The global infectious disease diagnostics market is estimated to be valued at US$ 1,131.4 Mn, in terms of value in 2020 and is expected to reach US$ 1,841.2 Mn by the end of 2027.

Global Infectious Disease Diagnostics Market: Drivers

The increasing initiatives by organizations to address diagnostic challenges in emerging economies is expected to fuel growth of the global infectious disease diagnostics market over the forecast period. For instance, in January 2018, the Foundation for Innovative New Diagnostics entered into a collaboration with Becton, Dickinson, and Company (BD), Fondation Botnar, the Global Antibiotic Research & Development Partnership (GARDP), the Drugs for Neglected Diseases Initiative (DNDi), and the South African Medical Research Council (SAMRC) to address antimicrobial resistance (AMR) by accelerating the use of diagnostics.

Global Infectious Disease Diagnostics Market: Opportunities

Additionally, public and private initiatives to limit infectious diseases is the factor that is expected to offer lucrative growth opportunities for players in the market. For instance, Department of Health and Human Services announced a federal grant of US$ 750,000 to the city of Austin to help fight the spread of HIV/AIDS in Texas, U.S., in February 2020.

Global Infectious Disease Diagnostics Market: Restraints

However, low awareness and adoption of diagnostic services in emerging economies are the factors that are expected to hamper growth of the market over the forecast period. For instance, according to the Global AIDS UPDATE 2019 of UNAIDS, in Madagascar, Mauritius, and South Sudan, less than 25% of people living with HIV are aware of their status.

Key Takeaways:

Among technique, cell cultures segment in the global infectious disease diagnostics market was valued at US$ 362.3 Mn in 2018, and is estimated to reach US$ 747.4 Mn by 2027, exhibiting a CAGR of 8.3% over the forecast period. The segment growth is attributed to the cell culture technique, where various types of infections can be diagnosed using cell culture, where, microbes are grown in a laboratory setting to identify the same.

On the basis of disease indication, STDs segment accounted for major market share of 32.8%, in terms of value in the global infectious disease diagnostics market in 2018, followed by CNS infection, and respiratory infections, respectively. The growth of the segment is attributed to rising incidence of sexually transmitted disease, globally. Among 20 STDs, the most common STD’s include Gonorrhea, Chlamydia, Syphilis, Herpes, Hepatitis (HBV), and Human Immunodeficiency Virus (HIV). For instance, according to the Centers for Disease Control and Prevention (CDC), in 2016, 1,598,354 cases of Chlamydia trachomatis infection were reported in the U.S., corresponding to 497.3 cases per 100,000 in 2015.

On the basis of end user, diagnostic centers segment in the global infectious disease diagnostics market was valued at US$ 462.1 Mn in 2018 and is expected to reach US$ 958.7 Mn by 2027 exhibiting a CAGR of 8.5% over the forecast period. The segment growth is attributed to central diagnostic laboratories that are well equipped with latest diagnostic instruments, and have large resources to carry out multiple tests. Moreover, increasing number of tests are carried out in these centers on a daily basis, which is further expected to drive growth of the segment.

Purchase this Premium Report With Discount – https://www.coherentmarketinsights.com/promo/buynow/1971

Market Trends

Additionally, limited specificity of diagnostic tests available for infectious diseases triggers the need for combined diagnosis, which includes multiple tests. The trend of diagnosing a disease through multiple tests is gaining popularity.

Among regions, North America is expected to witness significant growth over the forecast period, attributed to increasing healthcare expenditure. For instance, according to the Centers for Medicare & Medicaid Services (CMS), healthcare spending in the U.S. is estimated to grow at an average rate of 5.5% per year during 2018-2027, and to reach nearly US$ 6.0 trillion by 2027. However, the reimbursement scenario for diagnostic tests is comparatively low.

Major Players Are Operating In This Market Are: Becton Dickinson & Company, Cepheid, Inc., Abbott Laboratories, BioMerieux SA, Hologic, Inc., Danaher Corporation, Thermo Fisher Scientific, Inc., Roche Diagnostics, Alera Inc., DiaSorin S.p.A., Quidel Corporation, and Bio-Rad Laboratories, Inc.

Highlights of the Infectious Disease Diagnostics report:

1. A complete backdrop analysis, which includes an assessment of the Infectious Disease Diagnostics Market
2. An objective assessment of the trajectory of the market
3. Market segmentation up to the second or third level
4. Reporting and evaluation of recent industry developments
5. Important changes in market dynamics
6. Emerging niche segments and regional markets
7. Historical, current, and projected size of the market from the standpoint of both value and volume
8. Market shares and strategies of key players
9. Recommendations to companies for strengthening their foothold in the market

To conclude, the Infectious Disease Diagnostics Market report mentions the key geographies, market landscapes alongside the production and consumption analysis, supply and demand analysis, market growth rate, along with future forecast etc. This report also provides SWOT and PEST analysis, investment feasibility and return analysis. Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report.

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.